Treatment trajectories and switching of drug within the same drug class Between 1 January 2017 and 31 December 2019, 35,105 patients initiated treatment with a GLP-1 receptor agonist (liraglutide: 22,008 [62.7%]
Effect of GLP-1 based therapies on diabetic dyslipidemia
more than 730 reports of adverse events associated with compounded tirzepatide
And when problems do pop up, theyre typically very treatable with great outcomes
Diet Approach #3: Low-Carb A low-carb diet is still a high-fat diet, but there is more allowance for whole, unprocessed carbohydrates, such as fruits and vegetables
The FDA created a green list alert to flag imported GLP-1 active ingredients that may have quality concerns, the spokesperson said, but they noted that the list does not create new limits on legal compounding of drugs